Nr 566 week 7 final exam - Study guides, Class notes & Summaries

NR 566 (Latest 2024 / 2025) Final Exam Week 7 Advanced Pharmacology for Care of the Family - Chamberlain Questions and Answers (Verified Answers)

NR 566 Test Bank Questions for Weeks 5-7 Week 5: Ch. 18, 19, 27, 37 Week 6: Ch. 22, 31, 38, 44 Week 7: 48, 49, 50, 51

NR 566 / NR566 Advanced Pharmacology for Care of the Family Final Exam Review| Rated A |Latest 2021 / 2022| Chamberlain College 1. Anticoagulant preferred for high risk of CVA with Afib - The 2012 ACCP guidelines recommend 150 mg of dabigatran twice daily as the anticoagulant therapy of choice rather than warfarin - For patients with persistent or paroxysmal AF at high risk for stroke, the recommendation is warfarin with a target INR between 2 and 3. 2. Drugs which decrease a...

NR 566 / NR566 Advanced Pharmacology for Care of the Family Final Exam Review Latest 2021 / 2022| Chamberlain College 1. Antiplatelet drugs - *ASA - inhibits cycloxygenase - interferes with platelet aggregation - *Clopidogrel and Ticlodipine - reduces platelet aggregation by inhibiting adenosine diphosphate pathway 2. Antiplatelet Pharmacokinetics - *ASA - well absorbed orally - metabolized in liver - renally excreted (pH effects excretion) - *Ticlopidine - rapidly absorbe...

 Antacids: weak bases that react with hydrochloric acid to form salt & water. o Used in the treatment of Hyperacidity, GERD, PUD, hyperphosphatemia, and calcium deficiency o Contain combinations of  metallic cation (aluminum, calcium, magnesium, and sodium)  and basic anion (hydroxide, bicarbonate, carbonate, citrate, and trisilicate)  Pharmacodynamics, Pharmacokinetics, Pharmacotherapeutics o Neutralize Gastric Acidity (causes ^pH of the stomach and duodenal bulb) o Inhibit proteoly...

NR 566 Final Exam Study Guide Week 5 Prevention of osteoporosis with hormone replacement therapy (p. 433) Hormone therapy (HT) reduces postmenopausal bone loss & thereby decreases the risk for osteoporosis & related fractures. Unfortunately, when HT is stopped, bone mass rapidly decreases by approximately 12%. Hence to maintain bone health, HT must continue lifelong. As a result, the risk for harm is increased. Accordingly, alternative treatments are preferred. Effective alternatives to HT inclu...

NR 566 Final Exam Study Guide Week 5 Prevention of osteoporosis with hormone replacement therapy (p. 433) Hormone therapy (HT) reduces postmenopausal bone loss & thereby decreases the risk for osteoporosis & related fractures. Unfortunately, when HT is stopped, bone mass rapidly decreases by approximately 12%. Hence to maintain bone health, HT must continue lifelong. As a result, the risk for harm is increased. Accordingly, alternative treatments are preferred. Effective alternatives to HT...

NR 566 Final Exam Study Guide Week 5 Prevention of osteoporosis with hormone replacement therapy (p. 433) Hormone therapy (HT) reduces postmenopausal bone loss & thereby decreases the risk for osteoporosis & related fractures. Unfortunately, when HT is stopped, bone mass rapidly decreases by approximately 12%. Hence to maintain bone health, HT must continue lifelong. As a result, the risk for harm is increased. Accordingly, alternative treatments are preferred. Effective alternatives to HT inclu...

NR 566 Final Exam Study Guide Week 5 Prevention of osteoporosis with hormone replacement therapy (p. 433) Hormone therapy (HT) reduces postmenopausal bone loss & thereby decreases the risk for osteoporosis & related fractures. Unfortunately, when HT is stopped, bone mass rapidly decreases by approximately 12%. Hence to maintain bone health, HT must continue lifelong. As a result, the risk for harm is increased. Accordingly, alternative treatments are preferred. Effective alternatives to HT...

566 Final Exam Study Guide Week 5 Prevention of osteoporosis with hormone replacement therapy (p. 433) Hormone therapy (HT) reduces postmenopausal bone loss & thereby decreases the risk for osteoporosis & related fractures. Unfortunately, when HT is stopped, bone mass rapidly decreases by approximately 12%. Hence to maintain bone health, HT must continue lifelong. As a result, the risk for harm is increased. Accordingly, alternative treatments are preferred. Effective alternatives to HT in...